A clinical trial assessing Cadonilimab in combination with CD47 monoclonal antibody ( AK117)
Latest Information Update: 28 Oct 2021
At a glance
- Drugs Cadonilimab (Primary) ; Ligufalimab (Primary)
- Indications Solid tumours
- Focus Adverse reactions
- Sponsors Akeso Biopharma
- 28 Oct 2021 New trial record